Updates on pediatric sepsis

Andrea T Cruz1, Roni D Lane2, Fran Balamuth3

  • 1Sections of Emergency Medicine and Infectious Disease Department of Pediatrics Baylor College of Medicine Houston Texas USA.

Insights

Recognizing and treating pediatric sepsis in the emergency department (ED) is critical. Updated guidelines and quality improvement programs aid in timely interventions for better outcomes in children with sepsis.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Emergency medicine

Background:

  • Pediatric sepsis presents diagnostic challenges in the ED due to non-specific symptoms and children's compensatory mechanisms.
  • Timely recognition and treatment are crucial for improving sepsis outcomes in children, reducing morbidity and mortality.

Purpose of the Study:

  • To review clinical, laboratory, and technical tools for recognizing, treating, and reassessing pediatric sepsis in the ED.
  • To frame the 2020 updated pediatric sepsis guidelines within ED interventions.

Main Methods:

  • Review of clinical, laboratory, and technical modalities for sepsis recognition and management.
  • Analysis of the 2020 updated pediatric sepsis guidelines, focusing on ED interventions.
  • Discussion of evidence gaps and the need for further research.

Main Results:

  • Quality improvement programs have enhanced sepsis treatment reliability in US institutions.
  • The 2020 guidelines provide updated recommendations for antibiotic administration, fluid resuscitation, and vasoactive agents in pediatric sepsis.
  • Limited evidence base for treatment and management components necessitates further large-scale trials.

Conclusions:

  • Despite substantial burden, progress in understanding and managing pediatric sepsis has led to revised guidelines.
  • Local quality improvement programs are emphasized for optimizing sepsis management in children.
  • Ongoing research is vital to strengthen the evidence base for pediatric sepsis treatment.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
170
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
122
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
624
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
662
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
100
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
150